Safety and efficacy of high-dose G-CSF (24 mcg/kg) for PBSC mobilisation in children

被引:0
|
作者
Alcorta, I
Estella, J
Toll, T
Rives, S
Mateo, M
机构
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S305 / S305
页数:1
相关论文
共 50 条
  • [41] Platelet recovery after high-dose (HD) chemotherapy (C) is superior with peripheral blood stem cells (PBSC) mobilized by C+G-CSF compared to G-CSF alone
    Crump, M
    Yee, K
    Imrie, K
    Couban, S
    Stewart, AK
    Saragosa, R
    Keating, A
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 397 - 397
  • [42] Comparable efficacy and lower cost of PBSC mobilization with intermediate-dose cyclophosphamide and G-CSF compared with plerixafor and G-CSF in patients with multiple myeloma treated with novel therapies
    F Awan
    S T Kochuparambil
    D E Falconer
    A Cumpston
    S Leadmon
    K Watkins
    D DeRemer
    A Jillella
    M Craig
    M Hamadani
    Bone Marrow Transplantation, 2013, 48 : 1279 - 1284
  • [43] Efficient mobilisation of peripheral blood stem cells (PBSC) with HiDAC plus Amsacrine plus G-CSF but not with mini-ICE plus G-CSF in patients with AML
    Hoglund, M
    Brune, M
    Sallerfors, B
    Ahlgren, T
    Billstrom, R
    Hedenus, M
    Markevarn, B
    Simonsson, B
    Stockelberg, D
    Wahlin, A
    BLOOD, 2001, 98 (11) : 177A - 177A
  • [44] CIRCULATING PROGENITORS IN LYMPHOMA PATIENTS TREATED WITH HIGH-DOSE SEQUENTIAL CHEMOTHERAPY AND G-CSF
    TARELLA, C
    CARACCIOLO, D
    GAVAROTTI, P
    BENEDETTI, G
    BONDESAN, P
    CASTELLINO, C
    CHERASCO, C
    PILERI, A
    BLOOD, 1993, 82 (10) : A654 - A654
  • [45] Evaluating the clinical efficiacy of etoposide (VP-16) +G-CSF 10 mcg/kg for peripheral blood progenitor cell mobilisation in patients with acute myeloid leukaemia
    Pivkova, A
    Cevreska, L
    Siljanovski, N
    Stojanoski, Z
    Stavrik, SG
    Panovska, L
    Balkanov, SK
    Trajkova, S
    Georgievski, B
    BONE MARROW TRANSPLANTATION, 2006, 37 : S124 - S125
  • [46] Collection of peripheral blood stem cells (PBSC) in multiple myeloma (MM) following G-CSF with or without high-dose cyclophosphamide (HD-CTX).
    Desikan, KR
    Jagannath, S
    Vesole, D
    Bracy, D
    Nelson, J
    Tindle, S
    Barlogie, B
    Tricot, G
    BLOOD, 1995, 86 (10) : 1594 - 1594
  • [47] PBSC COLLECTION AFTER HIGH-DOSE CHEMOTHERAPY FOLLOWED BY G-CSF IN PATIENTS WITH MALIGNANCIES - ANALYSIS OF RESULTS REGARDING FACTORS AFFECTING THE YIELD OF HEMATOPOIETIC PROGENITORS
    OLIVIERI, A
    OFFIDANI, M
    CINIERO, L
    POLONI, A
    TEDESCHI, A
    REFE, MC
    STRUSI, AS
    LEONI, P
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1993, 16 : 57 - 63
  • [48] PERIPHERAL-BLOOD STEM-CELL (PBSC) REINFUSION AND G-CSF IN REFRACTORY OVARIAN-CARCINOMA AFTER HIGH-DOSE CARBOPLATINUM (CBDCA)
    LITAM, PP
    ZAMKOFF, KW
    MUSA, A
    DRACKER, R
    CERMINARO, A
    FIELDS, SZ
    BLOOD, 1993, 82 (10) : A635 - A635
  • [49] Sufficient mobilisation of peripheral blood stem cells by single dose of pegylated G-CSF compared with daily G-CSF in patients with lymphoproliferative malignancies
    Putkonen, M
    Itälä, M
    Kauppila, M
    Rauhala, A
    Remes, K
    BONE MARROW TRANSPLANTATION, 2006, 37 : S160 - S160
  • [50] A clinical comparison of the efficacy and safety of biosimilar G-CSF and originator G-CSF in haematopoietic stem cell mobilization
    Joanna Manko
    Adam Walter-Croneck
    Dariusz Jawniak
    Norbert Grzasko
    Magdalena Gorska-Kosicka
    Maria Cioch
    Anna Dmoszynska
    Pharmacological Reports, 2014, 66 : 239 - 242